Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension

By Melanie Calvert, Derek G Kyte, R. Mercieca-Bebber, A. Slade, A. Chan, M. King, Amanda Hunn, A. Bottomley, A. Regnault, C. Ells and 25 more. Journal of the American Medical Association (JAMA), 2018

679 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Oncology, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/aa01dfa45475b579b39f15e53483a60bfa64af38

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Colombo
2. A. Bois
3. C. Sessa
4. W. McCluggage
5. I. Vergote
6. P. Morice
7. J. Ledermann
8. M. Mirza

Citations in the corpus

• ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. (2019, methodology): “297–300 The Standard Protocol Items: Recommendations for Interventional Trials patient-reported outcome (SPIRIT-PRO) guidelines could be used for preplanned PROs hypothesis.(301) Currently, there are several QoL questionnaires available, such as the functional assessment of cancer therapy (FACT) Ova”